Efficacy of Dysport on erectile dysfunctio

Phase 2

Recruiting

• Conditions: Male erectile dysfunction, unspecified; Erectile dysfunction.; N52.9

• Registration Number: IRCT20201119049439N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

40 to 70 years of age
Erectile Dysfunction proved by colour doppler sonography
Failure to response to first lines treatments

Exclusion Criteria

significant cardiovascular diseases that interfere with erectile function
History of unstable physical and psychological situations
Anatomical abnormalities of the penis
Hormonal disorders
History of spinal cord or pelvic radical surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Peak systolic velocity in cavernosal artery. Timepoint: Before and after Intracavernosal injection of 50 and 100 units Dysport. Method of measurement: Sonography.;End diastolic velocity in cavernosal artery. Timepoint: Before and after Intracavernosal injection of 50 and 100 units Dysport. Method of measurement: Sonography.;International Index of Erectile Function(IIEF). Timepoint: Before and after Intracavernosal injection of 50 and 100 units Dysport. Method of measurement: Questionnaire.;Sexual Health Inventory for Men(SHIM SCORE). Timepoint: Before and after Intracavernosal injection of 50 and 100 units Dysport. Method of measurement: Questionnaire.;Erection Hardness Score. Timepoint: Before and after Intracavernosal injection of 50 and 100 units Dysport. Method of measurement: Questionnaire.